Authors:
STRICKLER HD
SCHIFFMAN MH
SHAH KV
RABKIN CS
SCHILLER JT
WACHOLDER S
CLAYMAN B
VISCIDI RP
Citation: Hd. Strickler et al., A SURVEY OF HUMAN-PAPILLOMAVIRUS-16 ANTIBODIES IN PATIENTS WITH EPITHELIAL CANCERS, European journal of cancer prevention, 7(4), 1998, pp. 305-313
Authors:
VISCIDI RP
KOTLOFF KL
CLAYMAN B
RUSS K
SHAPIRO S
SHAH KV
Citation: Rp. Viscidi et al., PREVALENCE OF ANTIBODIES TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN RELATION TO CERVICAL HPV INFECTION AMONG COLLEGE-WOMEN, Clinical and diagnostic laboratory immunology, 4(2), 1997, pp. 122-126
Authors:
SHAH KV
VISCIDI RP
ALBERG AJ
HELZLSOUER KJ
COMSTOCK GW
Citation: Kv. Shah et al., ANTIBODIES TO HUMAN PAPILLOMAVIRUS-16 AND SUBSEQUENT IN-SITU OR INVASIVE CANCER OF THE CERVIX, Cancer epidemiology, biomarkers & prevention, 6(4), 1997, pp. 233-237
Authors:
STRICKLER HD
HILDESHEIM A
VISCIDI RP
SHAH KV
GOEBEL B
DRUMMOND J
WATERS D
SUN YP
HUBBERT NL
WACHOLDER S
BRINTON LA
HAN CL
NASCA PC
MCCLIMENS R
TURK K
DEVAIRAKKAM V
LEITMAN S
MARTIN C
SCHILLER JT
Citation: Hd. Strickler et al., INTERLABORATORY AGREEMENT AMONG RESULTS OF HUMAN PAPILLOMAVIRUS TYPE-16 ENZYME-LINKED IMMUNOSORBENT ASSAYS, Journal of clinical microbiology, 35(7), 1997, pp. 1751-1756
Authors:
IYENGAR S
SHAH KV
KOTLOFF KL
GHIM SJ
VISCIDI RP
Citation: S. Iyengar et al., SELF-ASSEMBLY OF IN VITRO-TRANSLATED HUMAN PAPILLOMAVIRUS TYPE-16 L1 CAPSID PROTEIN INTO VIRUS-LIKE PARTICLES AND ANTIGENIC REACTIVITY OF THE PROTEIN, Clinical and diagnostic laboratory immunology, 3(6), 1996, pp. 733-739
Authors:
WU TC
GUARNIERI FG
STAVELEYOCARROLL KF
VISCIDI RP
LEVITSKY HI
HEDRICK L
CHO KR
AUGUST JT
PARDOLL DM
Citation: Tc. Wu et al., ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PRESENTATION OF ANTIGENS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(25), 1995, pp. 11671-11675
Authors:
WU TC
LIN K
VISCIDI RP
PARDOLL DM
KUMAN RJ
Citation: Tc. Wu et al., LEVELS OF ANTI-HPV16 E7 ANTIBODY CORRELATE WITH TUMOR BURDEN IN A MURINE MODEL, Laboratory investigation, 72(1), 1995, pp. 99-99
Authors:
WU TC
GUARNIERI FG
VISCIDI RP
HEDRICK L
CHO KR
AUGUST JH
PARDOLL DM
Citation: Tc. Wu et al., A NEW STRATEGY FOR ENHANCING MHC CLASS-II PRESENTATION OF ENDOGENOUS ANTIGENS, Laboratory investigation, 72(1), 1995, pp. 127-127
Authors:
STRUNNIKOVA N
RAY SC
LIVINGSTON RA
RUBALCABA E
VISCIDI RP
Citation: N. Strunnikova et al., CONVERGENT EVOLUTION WITHIN THE V3 LOOP DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN ASSOCIATION WITH DISEASE PROGRESSION, Journal of virology, 69(12), 1995, pp. 7548-7558
Authors:
MULLER M
VISCIDI RP
ULKEN V
BAVINCK JNB
HILL PM
FISHER SG
REID R
MUNOZ N
SCHNEIDER A
SHAH KV
GISSMANN L
Citation: M. Muller et al., ANTIBODIES TO THE E4, E6, AND E7 PROTEINS OF HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 IN PATIENTS WITH HPV-ASSOCIATED DISEASES AND IN THE NORMAL POPULATION, Journal of investigative dermatology, 104(1), 1995, pp. 138-141
Authors:
SUN YP
ELUFNETO J
BOSCH FX
MUNOZ N
BOOTH M
WALBOOMERS JMM
SHAH KV
VISCIDI RP
Citation: Yp. Sun et al., HUMAN PAPILLOMAVIRUS-RELATED SEROLOGICAL MARKERS OF INVASIVE CERVICAL-CARCINOMA IN BRAZIL, Cancer epidemiology, biomarkers & prevention, 3(4), 1994, pp. 341-347
Authors:
SUN YP
SHAH KV
MULLER M
MUNOZ N
BOSCH XF
VISCIDI RP
Citation: Yp. Sun et al., COMPARISON OF PEPTIDE ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND RADIOIMMUNOPRECIPITATION ASSAY WITH IN VITRO-TRANSLATED PROTEINS FOR DETECTION OF SERUM ANTIBODIES TO HUMAN PAPILLOMAVIRUS TYPE-16 E6 AND E7 PROTEINS, Journal of clinical microbiology, 32(9), 1994, pp. 2216-2220
Citation: Rp. Viscidi et al., TRANSMISSION OF CHLAMYDIA-TRACHOMATIS AMONG SEX PARTNERS ASSESSED BY POLYMERASE CHAIN-REACTION, The Journal of infectious diseases, 168(2), 1993, pp. 488-492
Authors:
VISCIDI RP
SUN Y
TSUZAKI B
BOSCH FX
MUNOZ N
SHAH KV
Citation: Rp. Viscidi et al., SEROLOGIC RESPONSE IN HUMAN PAPILLOMAVIRUS-ASSOCIATED INVASIVE CERVICAL-CANCER, International journal of cancer, 55(5), 1993, pp. 780-784